New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
16:31 EDTIIVI, BOX, VZ, TRV, ARNA, MSFT, DD, RIMM, DELL, JNJOn The Fly: Closing Wrap
Stocks on Wall Street were slightly higher after four Dow components reported mixed quarterly results before the bell. The earnings calendar is fairly heavy again after the bell, as investors receive results from tech giants Google (GOOG) and International Business Machines (IBM) among those reporting... ECONOMIC EVENTS: In the U.S., sales of existing homes unexpectedly dropped 1% in December to a 4.94M annual rate, versus expectations for sales to increase to a 5.1M rate. Two regional Fed surveys were also reported, with the Chicago Fed National Activity Index slipping but remaining positive at 0.02, while the Richmond Fed Manufacturing Survey plunged 17 points to -12... COMPANY NEWS: Among the four Dow members reporting results, Travelers (TRV) was the leader, gaining $1.64, or 2.15%, to $77.95 after its better than expected earnings. Shares of DuPont (DD) and Verizon (VZ) were also higher. Johnson & Johnson (JNJ) slid 54c, or 0.74%, to $72.69 after its quarterly report in spite of announcing plans to explore options for its Ortho Clinical Diagnostics unit, including a potential sale or spin-off... Microsoft (MSFT) is in talks to invest between $1B-$3B as part of a leveraged buyout of Dell (DELL), according to CNBC's David Faber. Dell spiked higher following the news, finishing up 28c, or 2.18%, at $13.12, while Microsoft lost 8c, or 0.29%, to $27.17... MAJOR MOVERS: Among the notable gainers was SeaCube (BOX), up $2.84, or 13.99%, to $23.14 after agreeing to be acquired by Ontario Teachers' Pension for $23 per share. Also higher were shares of Research In Motion (RIMM), which rose $2.06, or 13.01%, to $17.90 after its CEO reportedly said it may license the BB10 operating system and shares were upgraded to Outperform at Scotia Capital with a $23 price target. Among the noteworthy losers was Arena Pharmaceuticals (ARNA), which lost 95c, or 9.72%, to $8.82 after the European Medicines Agency asked it to address issues with its anti-obesity drug. Also lower were shares of II-VI (IIVI), down $1.87, or 9.51%, to $17.80 after the company's Q2 report fell short of expectations and its FY13 guidance came in below Street estimates... INDICES: The Dow was up 62.43, or 0.46%, to 13,712.13; the Nasdaq was up 8.47, or 0.27%, to 3,143.18; and the S&P 500 was up 6.53, or 0.44%, to 1,492.51.
News For TRV;JNJ;DD;VZ;DELL;MSFT;BOX;RIMM;ARNA;IIVI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
April 14, 2015
07:58 EDTDDDuPont CEO says Peltz wrongly focusing on short-term, WSJ reports
In an interview with The Wall Street Journal, DuPont CEO Ellen Kullman argued that Trian Fund Management's Nelson Peltz is pushing a short-term agenda, stating “Can you cut costs and create a bump short-term? Yes, but where are you going to be in two years, in five years? Do you exist in 10?” Kullman added that Trian lacks the expertise and the patience needed to guide a company whose products may require a decade or more to launch, the Journal added. Reference Link
07:50 EDTJNJJohnson & Johnson reports Q1 Worldwide Consumer sales $3.4B
Subscribe for More Information
07:48 EDTJNJJohnson & Johnson cuts FY15 adjusted EPS to $6.04-$6.19 from $6.12-$6.27
Subscribe for More Information
07:46 EDTJNJJohnson & Johnson reports Q1 domestic sales up 5.9% to $8.69B
Subscribe for More Information
07:45 EDTJNJJohnson & Johnson reports Q1 adjusted EPS $1.56, consensus $1.54
Subscribe for More Information
05:46 EDTMSFTMicrosoft's Surface 3 expected to see weak sales, DigiTimes Research reports
Microsoft's Surface 3 is expected to see low shipments and weak sales due to fiercer competition than those for its Surface Pro 3, reports DigiTimes Research. The Surface 3, priced over $600, is expected to only have limited impact on other branded 2-in-1 products, which are priced below $350 on average. Reference Link
05:46 EDTMSFTMicrosoft offers fee cut to attract vendors to pre-install apps, DigiTimes says
Subscribe for More Information
April 13, 2015
20:16 EDTVZUSTelecom files net neutrality lawsuit against FCC
Subscribe for More Information
17:10 EDTJNJIBM establishes a Watson Health Cloud
Subscribe for More Information
16:21 EDTJNJOn The Fly: Top stock stories for Monday
Subscribe for More Information
15:38 EDTJNJNotable companies reporting before tomorrow's open
Subscribe for More Information
15:08 EDTJNJJohnson & Johnson April 100 straddle priced for 2.2% movement into Q1
14:07 EDTJNJEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information
13:28 EDTJNJJohnson & Johnson April volatility elevated into Q1 and outlook
Subscribe for More Information
12:02 EDTMSFTMicrosoft hires Kurt DelBene to head corporate strategy and planning
Microsoft announced that Kurt DelBene has been named executive vice president of Corporate Strategy and Planning reporting to Microsoft CEO Satya Nadella. DelBene is returning to Microsoft, where he was most recently president of the Microsoft Office Division. After leaving Microsoft in 2013, he then served as senior advisor to the Secretary of Health and Human Services where he was appointed by President Obama to oversee implementation and improvement of Healthcare.gov. He most recently has been a venture partner at Madrona Venture Group, concentrating on investing and advising in early stage, technology-focused startups in the Pacific Northwest.
11:12 EDTJNJJohnson & Johnson technical notes before earnings
Leading up to earnings, the shares have been trading in a narrow range largely bound by $98 at the low and $103 at the high. This trading range was preceded by a decline from the 52-week high set back in the fall of 2014. In a longer time frame, the current trading action is part of a larger potential topping process, with $95 as the midpoint. On worse than expected news, the low bound at $98 would be first important support. A breakdown below $98 would see next support at $95. A move below $95 would confirm the topping process and break the long-term uptrend. Support below $95 would be at $93.94. If results and outlook are better than expected, first resistance would be at the top of the range at $103. Next resistance would then be at $105.36. A move above that level would see $107.10, and then 52-week high and life high at $109.49 as next potential upside objectives.
09:53 EDTDDTrian's Garden says 'very confident' in winning DuPont board seats
Ed Garden, Chief Investment Officer of Trian Partners, is speaking on CNBC.
09:52 EDTDDTrian's Garden says something wrong with DuPont R&D spending
Subscribe for More Information
07:46 EDTTRVTravelers to acquire majority interest in property casualty business of JV
Subscribe for More Information
07:16 EDTVZTechWeek to hold a conference
TechWeek Detroit 2015 is being held in Detroit on 4/13-19.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use